Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Recludix Pharma Inc.

Headquarters: San Diego, CA, United States of America
Year Founded: 2019
Status: Private

BioCentury | Apr 24, 2024
Management Tracks

Evotec names Christian Wojczewski CEO

Plus: Novartis proposes Giovanni Caforio as chair and updates from Congruence, Recludix, Calluna and more
BioCentury | Sep 27, 2023
Deals

Insilico’s evolving AI deals: from ‘death by pilot’ to $80M up front

The AI company’s Exelixis partnership highlights its strategic pivots in a shifting landscape 
BioCentury | Aug 8, 2023
Emerging Company Profile

Recludix: targeting STATs via their SH2 domains

San Diego company’s STAT6 program is partnered with Sanofi 
BioCentury | Jul 21, 2023
Deals

July 20 Quick Takes: Via its second preclinical deal this week, Sanofi gains Recludix’s oral STAT6 inhibitor

Plus: Idorsia sells Japan, Korea business to Sosei and updates from Gossamer and BioNTech-Biotheus
BioCentury | Oct 20, 2022
Management Tracks

5AM hires Anna Yaeger as head of public equities

Plus Scripps alum Maricich becomes Ashvattha CMO and updates from Alexion, Rewind, ExeVir and more
BioCentury | Nov 17, 2021
Management Tracks

Rhee steps down as CEO of Korea’s SCM

Recludix, Ankyra unveil venture rounds and new execs; plus ImmunoGen, Talis, Kira, Sonoma, Spruce, Ankyra and more
Items per page:
1 - 6 of 6